Introduction interactions with ElA (Eckner et al., 1994) . These two proteins share extensive regions of homology throughNuclear receptors are ligand-dependent transcription out, including regions of interaction with CREB (Chrivia factors that regulate diverse aspects of growth, developet al., 1993) , E1A Arany et al., ment , and homeostasis by binding as homodimers or 1995), TFIIB (Kwok et al., 1994) , and c-Fos (Bannister heterodimers to their cognate DNA elements (Yu et al., and Kouzarides, 1995) , as well as a bromodomain (Arany 1991; Bugge et al., 1992; Kliewer et al., 1992; Leid et al., et al., 1994) . Several independent approaches, involving Marks et al., 1992; Zhang et al., 1992; Chambon, cotransfection assays or microinjection of anti-CBP an-1994; Tsai and O'Malley, 1994;  tibody and reporter, have revealed that CBP is required Mangelsdorf et al., 1995) . Transactivation by nuclear for activation of both CREB and AP-1 (Kwok et al., 1994 ; receptors depends on a conserved motif within the distal Arias et al., 1994) . C-terminus, referred to as the AF2 domain. Several lines
In this paper, we demonstrate that the ligand-binding of evidence indicate that nuclear receptors must interact domains of multiple nuclear receptors, including RAR with additional factors dependent on a conserved distal and GR, interact strongly in the cell with a conserved C-terminal motif (AF2) to mediate both activation and domain in the N-terminus of CBP and p300 in a ligandrepression of gene expression (Cavailles et al., 1994;  dependent manner. Further, the putative coactivator Halachmi et al., 1994; Baniahmad et al., 1995; p160 was found to interact independently and specifi Chen and Evans, 1995; Kurokawa et al., cally with a conserved C-terminal domain in CBP and 1995). Biochemical assays have identified 140 and 160 p300. Expression cloning of p160 cDNAs based on nukDa proteins (p140 and p160) (Halachmi et al., 1994;  clear receptor and CBP interaction surprisingly revealed their identity as variants of SRC-1. Several independent experimental approaches have suggested a central role 6 The contributions of these authors are to be considered equivalent.
for CBP in ligand-dependent activation of RAR and T3R, 7 Present address: Institute of Molecular and Cellular Biology, National University of Singapore, Singapore 0511.
comparable to its role for CREB and Jun/Fos. Our data indicate competition for limiting amounts of CBP may functions of nuclear receptors. Although CBP is widely account for many of the inhibitory actions of both GR expressed, its low levels are rate limiting for CREBand RAR on AP-1 activation. We propose that CBP/p300 mediated transcription, which permitted cotransfection is a required component common to the coactivator assays to evaluate a role for CBP in CREB-dependent complexes of diverse transcription factors, each utilizing transcription (Kwok et al., 1994) . We therefore examined specific additional coactivators, thus providing a mechligand-dependent transcription from a retinoic acid reanism for integrating in the nucleus diverse signaling sponse element (RARE) containing promoter in the prespathways in the maintenance of homeostasis.
ence and absence of coexpressed CBP. Expression of CBP led to a 3-fold further enhancement of retinoic Results acid-dependent transcription, but had little or no effect on promoters lacking a RARE ( Figure 2A ). To acquire Nuclear Receptors Directly Interact with CBP further, independent evidence for a potential role of CBP To investigate possible direct interactions between nuin RAR-mediated transcription, we performed in vitro clear receptors and CBP, a series of overlapping fragtranscription assays using nuclear extracts prepared ments of the 265 kDa CBP protein were bacterially from cells with varied levels of CBP. To be certain that expressed as glutathione S-transferase (GST) fusion the effects of CBP were exerted through the ligandproteins and tested for interaction with RAR, revealing binding domain of nuclear receptors, we utilized a a strong ligand-dependent interaction confined to a sin-GAL4-T 3 receptor fusion protein (Baniahmad et al., gle N-terminal CBP region ( Figure 1A ). The ability of this 1995). The ability of this fusion protein to activate the interaction to occur in intact cells in a ligand-dependent tk promoter-containing GAL4-binding elements (17-mer manner was confirmed using the yeast two-hybrid sysupstream activating sequence [UAS]) was assessed ustem ( Figure 1B ). Further mapping revealed that the ing GAL4 protein as a control. T 3 -induced transcription N-terminal 100 amino acids of CBP retained full interacof this UAS-driven reporter was increased >5-fold by tion with RAR; attempts to subdivide further this region additional CBP, while altered levels of CBP had little resulted in a complete loss of the capacity to interact. effect on transcription of several control promoters (FigConsistent with the ability of several nuclear receptors ure 2B). Increased levels of CBP also markedly into inhibit the activated AP-1 transcriptional response, creased AP-1 site-dependent reporter expression, we found that estrogen receptor (ER), T 3R, and RXR also consistent with the proposed role of CBP in AP-1 transexhibited strong ligand-dependent interactions with the activation events (Arias et al., 1994) and indicating that identical N-terminal domain of CBP, dependent upon a CBP is limiting in extracts used in in vitro transcription functional AF2 domain ( Figure 1C ). Intriguingly, a point assays. mutation outside of the AF2 domain that conferred domiBased on these suggestive results, the role of CBP, nant-negative functions to the RAR (Gly-303→Glu) (Saior highly related factors, in ligand-dependent transcriptou et al., 1994) also abolished interactions with CBP tional activation was directly tested by evaluating the ( Figure 1C ). Together, these data indicate that CBP ability of microinjected anti-CBP immunoglobulin G binds to the C-terminal domain of ligand-occupied nu-(IgG) to inhibit ligand-dependent transcription from clear receptors. These interactions were demonstrated RARE-containing promoters in intact cells. In each exto occur on DNA using the protein-dependent gel mobilperiment, >200 cells were injected with lacZ reporter ity shift assay, in which addition of an N-terminal fragplasmids and either control or anti-CBP IgG; cells were ment of CBP (amino acids 1-450) caused a marked sutreated with all-trans retinoic acid and stained with pershift of the RAR-RXR-DNA complex only in the X-Gal, and positive cells were counted. In these assays, presence of ligand ( Figure 1D ). The specificity of this addition of a ligand was required for effective expression interaction was established because the region of CBP of two independent RARE-dependent reporters, but did interacting with phosphorylated CREB (amino acids not affect other promoters not containing RAREs ( Figure  450 -720) failed to supershift RAR-RXR-DNA complexes 2C). In three independent experiments, coinjection of ( Figure 1D ).
increasing concentrations of anti-CBP IgG, but not conTo determine whether complexes between RAR and trol IgG, resulted in a progressive and specific decrease the CBP holoprotein occurred in the context of the intact in ligand-dependent gene activation, producing >80% cell, a vector encoding CBP with a C-terminal FLAG inhibition of ligand-induced activation. Even in the reepitope was constructed and expressed in a variety of maining 20% of cells that scored positive, there was cell types. Potential complexes were immunoprecipioften a reduced signal compared with levels in cells tated using RAR-specific antisera, fractionated on SDSinjected with control IgG. These data revealed that, in polyacrylamide gels, and analyzed by Western blot usa concentration-dependent fashion, anti-CBP IgG speing specific monoclonal anti-FLAG antibodies. These cifically inhibited ligand-dependent activation of tranassays established that ligand-dependent interactions scription units containing RAREs, without altering exbetween RAR and CBP occurred in vivo ( Figure 1E ). pression of other promoters. Furthermore, specific in vivo interactions with GR and RXR were demonstrated ( Figure 1E ).
The Nuclear Receptor-Associated p160 Coactivator Directly Interacts with CBP CBP Modulates Ligand-Dependent
Because CBP or its related family members (or both) Transcriptional Activation were required for transactivation by retinoic acid and Based on the in vivo interaction between the nuclear other nuclear receptors, we investigated the possibility receptors and CBP, it became of interest to evaluate the potential role of these interactions in ligand-dependent that putative nuclear receptor coactivators p140 or p160 M TTNPB). Fragments encompassing the entire CBP protein were used to generate inframe fusions with the B42 activation domain. LexA human RAR␣ (amino acids 143-462) was used as a bait. ␤-Galactosidase activity was assayed from Saccharomyces cerevisiae (EGY48) containing the pSH18-34 reporter plasmid to assess in vivo interactions (Gyuris et al., 1993) . (C) Several members of the nuclear receptor gene family interact with CBP in the yeast two-hybrid system. CBP N-terminus (amino acids 1-450) was used as a prey. Interaction of LexA fusion proteins encompassing the C-terminal ligand-binding domains of T 3R, RXR, RAR, and ER was measured in the presence or absence of the appropriate ligands. T 3 R Glu-403→Gln contains a mutation in the AF2 region. RAR ⌬403 has a C-terminal deletion at amino acid 403 of RAR␣ (Damm et al., 1993) . RAR Gly-303→Glu is a dominantnegative mutation (Saitou et al., 1994) , and RXR Glu-454→Gln contains a mutation in the AF2 region that renders it incapable of gene activation. ␤-Galactosidase activity was determined as described above. Ligands used were TRIAC (10 Ϫ7 M) for T3R, TTNPB (10 Ϫ7 M) for RAR, LG69 (10 Ϫ7 M) for RXR, and ␤-estradiol (10 Ϫ7 M) for ER. (D) CBP exhibits ligand-dependent interaction with RAR-RXR heterodimers on DNA. Interaction on DNA was assessed using a 32 P-labeled synthetic oligonucleotide encompassing the ␤-RARE and bacterially expressed, purified CBP N-terminus (amino acids 1-450). Brackets indicate RAR-RXR-bound DNA and the CBP-RAR-RXR-DNA complex. No mobility perturbation was observed using a comparable amount of the CREB-binding domain of CBP (amino acids 450-720). Efficacy of the CREB-binding domain of CBP was confirmed by its ability to bind protein kinase A-phosphorylated, but not unphosphorylated, CREB. (E) Ligand-dependent interactions between CBP and nuclear receptors in the intact cell. FLAG-tagged CBP was expressed by transient transfection in 293 cells. Anti-RAR, RXR, or GR antisera were used for immunoprecipitation of whole-cell extracts prepared from these cells in the presence or absence of 10 Ϫ7 M all-trans retinoic acid, 9-cis retinoic acid, or dexamethasone (DEX). Coimmunoprecipitation of CBP was examined by Western blot analysis using anti-FLAG antibody. The arrows indicate FLAG-CBP. Note that only full-length CBP, containing the N-terminal nuclear receptor interaction domain, but not the breakdown products, is coimmunoprecipitated.
could themselves interact with CBP. A series of GST identified between the C-terminal region of CBP and p160 ( Figure 3A ), but not with p140. These regions are fusion proteins spanning the entire sequence of CBP were used in interaction assays with extracts from distinct from the internal regions of CBP that interact with CREB, Fos, TFIIB, and E1A (Chrivia et al., 1993 ; various cell types. Proteins interacting with CBP fragments were fractionated by SDS-polyacrylamide gel Kwok et al., 1994; Arany et al., 1995; Bannister and Kouzarides, 1995; . To define betelectrophoresis (SDS-PAGE), transferred to nitrocellulose membranes, and detected using 32 P-labeled ER ter the determinants of p160 interaction, a series of fragments were generated from the CBP C-terminus, reveal-C-terminus in the presence of ligand. As expected, the N-terminal fragment of CBP interacted directly with nuing a region of 105 amino acids that was sufficient for interactions with p160 ( Figure 3A ). clear receptors. In addition, a specific interaction was (B) Increased CBP levels potentiate hormone-dependent transactivation by a GAL4-T 3R C-term inu s fus i on pro te in. In v itro transcription assays were performed with luciferase reporters driven by 3ϫ UAS(GAL)-tk, human papilloma virus 16 (HPV-16) or a 12-O-tetradecanoylphorbol-13-acetate (TPA) response element upstream of the prolactin minimal promoter (Drolet et al., 1991) (TREp36) . Increased CBP levels greatly enhanced the TRE-driven reporter, consistent with published results. Elevated CBP levels also increased transcription of the UAS(GAL)-tk-driven reporter by GAL4-T 3 R C-terminus fusion protein in the presence of hormone. In contrast, a viral promoter (HPV-16) containing an Sp1 site was not activated by elevated CBP levels. (C) Microinjection of anti-CBP antibody abrogates ligand-dependent gene activation by the RAR. Plasmids consisting of a lacZ reporter under the transcriptional control of RAREs were injected into the nuclei of Rat-l cells. RARE simian virus 40 (SV40) lacZ contains three copies of the DRϩ5 element upstream of the SV40 minimal promoter, whereas the RARE-p36 lacZ contains two copies of DRϩ5 upstream of the prolactin minimal promoter (Drolet et al., 1991) . Each construct was injected with preimmune IgG (no retinoic acid [RA]) or with affinity purified anti-CBP antibody and demonstrated a retinoic acid-dependent response. The expression of the reporter plasmids was monitored by X-Gal staining and quantitated based on the percentage of injected cells that stained blue. Coinjection of the same anti-CBP antibody did not inhibit expression of the reporters driven by either the SV40 or CMV viral enhancers. Photomicrographs of rhodaminestained injected cells (1-3) and the corresponding phase-contrast picture (4-6) of X-Gal staining show a typical result. In the absence of retinoic acid (1 and 4), background expression of ␤-galactosidase is minimal. Addition of 10 Ϫ6 M retinoic acid (2 and 5) results in a strong transcriptional response, which is significantly reduced in the presence of anti-CBP (3 and 6). X-Gal staining in some cells was sufficient to quench the rhodamine fluorescence (as in 2 and 5); therefore, the number of injected cells was counted as the sum of red or blue cells. All experiments were performed at least three separate times in which 200 or more cells were injected; error bars represent the SEM.
In addition, 32 P-labeled CBP C-terminus could detect CBP-associated T 3 R or RAR could occur ( Figure 3C ; data not shown). p160 in a biochemical interaction assay ( Figure 3B ). These observations raised the possibility that RAR, CBP, cDNAs encoding the putative p160 were obtained by expression cloning based on the criterion that phage and p160 could potentially form a ligand-dependent complex. Because both p160 and nuclear receptors inplaques exhibited interaction with both the CBP C-terminus and liganded nuclear receptors ( Figure 4 ). As illusteract with distinct domains in CBP holoprotein, it was possible to devise an assay that would unambiguously trated in Figure 4D , a series of cDNAs were identified that encoded variant forms of the SRC-1 protein reported to demonstrate the potential simultaneous interaction of nuclear receptors with both p160 and CBP. To achieve have a predicted molecular mass of 115 kDa (Oñ ate et al., 1995) . The N-terminally extended variants that we this, we used a GST fusion protein containing only the N-terminus of CBP to bind nuclear receptors in the presidentified included forms of 1465 and 1405 amino acids, with predicted molecular masses of 159 and 152 kDa. ence of cellular extracts containing p160. The data shown in Figure 3C utilized the T 3 R. Interacting protein This additional N-terminal sequence has revealed a homology with the A region of the PAS domain characteriswas probed on Western blots using 32 P-labeled ER C-terminus. These experiments revealed that ligand-detic of the PAS/helix-loop-helix (HLH) gene family (reviewed by Hankinson, 1995) . In addition, related factors pendent simultaneous interactions between p160 and The relative position of the CREB-binding domain, bromodomain, E1A, and TFIIB interaction domain and the glutamine-rich region in CBP are schematically represented. CV-1 whole-cell extracts were incubated with a series of GST-CBP fusion proteins, immobilized on glutathione-agarose. The whole-cell extracts were also incubated with GST-RAR C-terminus in the absence or presence of 10 Ϫ6 M all-trans retinoic acid. After washing, specifically associated proteins were resolved by SDS-PAGE, transferred to nitrocellulose, and detected using a [
32 P]GST-ER Cterminus in the presence of ligand. The numbers at the left indicate molecular size markers (kilodaltons). (B) Whole-cell extracts were incubated with a ligand-treated GST-ER bound to glutathione-agarose, and associated proteins were tested for interaction as described for (A) with either [ 32 P]GST-ER in the presence of ligand or [
32 P]GST-CBP C-terminus (amino acids 1892-2441). (C) Nuclear receptor, CBP, and p160 can simultaneously form a ligand-dependent protein complex. A GST fusion protein containing only the N-terminus of CBP (amino acids 1-450) was incubated with bacterially expressed T 3R in the presence or absence of ligand (10 Ϫ6 M TRIAC) and whole-cell extracts. After washing, specifically associated proteins were resolved by SDS-PAGE, transferred to nitrocellulose, and detected using [ 32 P]GST-ER in the presence of ligand as described. The control for identification of p160 was provided by analyzing proteins from the same whole-cell extract bound to GST-RAR in the presence of ligand.
exhibiting ‫%04ف‬ identity in the CBP and nuclear recepnuclear receptor family reported by Oñ ate et al. (1995) , indicating that p160 functions as a coactivator. tor interaction domains were identified (data not shown). Antiserum raised against an internal 50 kDa region common to all the recombinant SRC-1 variant proteins was found to interact specifically with a 160 kDa protein Both Nuclear Receptors and p160 Interact with Conserved Motifs on CBP and p300 doublet in whole-cell extracts that specifically interacted with GST-RAR in a ligand-dependent fashion (Figure While p300 was initially described based on its interaction with E1A (Eckner et al., 1994) , recent data confirmed 4B). Immunodepletion experiments demonstrated that approximately 75% of the biochemically defined p160 its ability to interact with both CREB and Jun/Fos; conversely, CBP interacts with E1A (Arany et al., 1995; Lundcould be removed from HeLa whole-cell extracts by this antiserum (Figure 4B ), indicating that the l59 kDa variant blad et al., 1995) . Although the regions of CBP found to mediate interaction with nuclear receptors and p160 of SRC-1 is the biochemically identified p160. The N-terminus of the cloned SRC-1 protein was capable of were not initially recognized as regions of high homology, comparison of the N-and C-terminal regions of forming a ternary complex with CBP and a liganded nuclear receptor ( Figure 4C) ; we have also observed CBP involved in these interactions with the corresponding region of p300 revealed multiple clusters of complete association between SRC-1-related factors. Cotransfection experiments confirmed that the SRC-1 variant identity in both the nuclear receptor interaction domain (amino acids 1-101, CBP; amino acids 1-117, p300) and potentiated the activity of RAR (data not shown) in concert with effects of SRC-1 on several members of the in the p160 interaction domain (amino acids 2058-2163, (Lin et al., 1992) were screened for proteins interacting with 32 P-labeled ligand-bound ER C-terminus. We identified 11 positive plaques from 1.5 ϫ 10 6 plaques evaluated, 7 of which also interacted with the [ 32 P]GST-CBP C-terminus (amino acids 2058-2163). (B) p160 is antigenically related to SRC-1. A guinea pig polyclonal antiserum was raised against a GST fusion of a 500 amino acid region common to all SRC-1 variants, encompassing the nuclear receptor and CBP interaction domains. This antiserum was used to immunodeplete reactive proteins from HeLa whole-cell extracts (lanes 3 and 7). Preimmune serum was used as a control (lanes 4 and 8). Treated and untreated whole-cell extracts were incubated with GST-RAR bound to glutathione-agarose, in the presence or absence of all-trans retinoic acid, to purify putative coactivator proteins. Following extensive washing, specifically bound proteins and GST-RAR were resolved by SDS-PAGE and transferred to a nitrocellulose membrane. The membrane was first probed with liganded [ 32 P]GST-ER to detect p140 and p160 (lanes 2 and 6). Pretreatment of HeLa extracts with SRC-1 antiserum, but not preimmune serum, resulted in a marked decrease in the p160 band detected by labeled ER (compare lanes 2 and 3). The membrane was then stripped and probed with anti-SRC-1 IgG. This demonstrated near quantitative (>75%) removal of the p160 recognized by specific antisera during the initial immunodepletion (compare lanes 6 and 7). (C) Nuclear receptors, CBP, and SRC-1 can form a ligand-dependent ternary protein complex. A protein-protein interaction assay was performed with GST-CBP (1-450), which contains only the nuclear receptor interaction domain, bacterially expressed His-T 3R, and in vitro translated activation of AP-1-dependent promoters. If competition for limiting quantities of CBP accounts for the inhibitory effect of nuclear receptors, then increased levels of CBP should restore AP-1-dependent activation. Indeed, the inhibitory effects of liganded RAR and GR were largely or completely abolished by cotransfection of vectors expressing CBP ( Figure 6A ). Cotransfection with vectors expressing p300 also diminished the AP-1 inhibitory effects of nuclear receptors, but appeared somewhat less effective than CBP ( Figure 6A ). Mutations in the RAR AF2 domain that inhibit binding of CBP and other coactivator proteins abolished AP-1 repression by nuclear receptors, consistent with previous data involving C-terminal receptor deletions (Desbois et al., 1991; Saatcioglu et al., 1994 ) (data not shown). The CBP-dependent inhibition of AP-1 activity could formally reflect either an allosteric effect whereby binding of nuclear receptors could preclude binding of the AP-1 complex to CBP or a competition for limiting amounts of CBP. However, the first possibility appears unlikely because we found that binding of nuclear receptors (RAR) and Jun could simultaneously occur on CBP (data not shown).
A recently described synthetic RAR ligand (LG550) exerts a potent anti-AP-1 effect, while LG629 serves as an antagonist ( Figure 6B) . Based on the model that CBP partitioning can mediate trans-repression of AP-1 by nuclear receptors, it would be predicted that LG550 might result in potent association with CBP. This possi- with all-trans retinoic acid, while interaction was abol-(B) Interaction between the N-terminus of p300 (amino acids ished by the antagonist, LG629. Further, using the yeast and CBP (amino acids 1-101) with RAR␣ C-terminus was assessed two-hybrid assay, LG550 was found to be a more potent using the yeast two-hybrid assays as described in the legend to Figure 1B. stimulator of CBP-RAR interactions than all-trans reti-(C) p300 (amino acids 2042-2160) and CBP (amino acids noic acid, while LG629 abolished interaction (data not were expressed as GST fusion proteins, bound to glutathioneshown). Finally, interactions in intact cells were asagarose, and incubated with whole-cell extracts. After washing, sessed by immunoprecipitation of CBP-containing comspecifically associated proteins were resolved by SDS-PAGE, transplexes after addition of various ligands. As shown in ferred to nitrocellulose, and then detected using [ 32 P]GST-ER in the presence of ligand as described for Figure 1A . The numbers at the Figure 6B , CBP-RAR interactions were markedly inleft indicate molecular size markers. creased when LG550 was added compared with cells treated with all-trans retinoic acid, and the interaction was abolished by LG629. Together, these observations CBP; amino acids 2042-2157, p300) ( Figure 5 ). Consisare consistent with the hypothesis that the interaction tent with these sequence homologies, the N-terminus between RAR and CBP is responsible for some forms of p300 interacted with the RAR in a ligand-dependent of repression of AP-1 activity. If this were the case, one manner, while its C-terminus interacted with p160 (Figwould predict that CREB, which appears to have a very ure 5). The strength of these interactions was comparahigh affinity for CBP, might be able actually to inhibit ble to those of the corresponding regions of CBP.
nuclear receptor activation. This possibility was tested by transfection of a RARE-dependent reporter and Role of CBP in Nuclear Receptor-Mediated cytomegalovirus (CMV)-CREB and retinoic acid-depenInhibition of AP-1 Activity dent induction after treatment of cells with 8-bromoIn parallel, we wished to explore a potential role for cAMP. Indeed, activated CREB reduced retinoic acid-CBP in mediation of ligand-dependent inhibition of AP-1 dependent stimulation from Ͼ40-fold to ‫-5ف‬fold ( Figure  function . To begin to test this hypothesis, we estab-6C), without affecting the basal activity of the RARElished a transfection assay in which liganded RAR or GR could effectively inhibit ‫)%08ف(‬ phorbol ester-mediated driven reporter. . The inhibition by retinoic acid was largely decreased or abolished when plasmids expressing either a CBP or p300 transcription unit were cotransfected (lower left). In a similar fashion, the repression by liganded GR was alleviated with cotransfection of CBP and partially recovered with overexpression of p300 (lower right). (B) LG550 enhances interactions between RAR and CBP. Whole-cell extracts were prepared from 293 cells expressing FLAG-CBP and immunoprecipitated with RAR antibody in the presence or absence of all-trans retinoic acid, LG550, or LG629 (10 Ϫ7 M). Western blot analysis was performed using anti-FLAG antibody. Transient transfection experiments similar to that described in (A) were done with LG550 and LG629 at two concentrations. Activity in the absence of ligand was arbitrarily defined as 100%. (C) Effects of overexpression of CREB on retinoic acid-stimulated gene expression. Increased CREB levels led to reduced retinoic acid stimulation of RARE-driven reporter in HeLa cells. Thus, the ‫-54ف‬fold induction of the reporter by retinoic acid was gradually reduced to ‫-5ف‬ fold with increasing amounts of CMV-CREB cotransfected. In all cases, 8-bromo-cAMP (1 mM) was administered together with retinoic acid (10 Ϫ7 M) to activate both pathways at the same time. The baseline expression of the reporter in the absence of retinoic acid and cAMP remained constant with increasing amount of cotransfected CREB. Similar results were obtained in P19 cells.
Discussion
cells, such as HeLa cells, containing little p140 ( Figure  4 ), our observations suggest that transcriptional activation by nuclear receptors is mediated by a complex Coactivator Complexes in Nuclear Receptor Transactivation Events that contains both CBP and p160 and probably other components. We have presented evidence that p160 Based on the data presented in this manuscript, we have found, unexpectedly, that CBP/p300 appear to be represents a major form of a family of SRC-1-related proteins. Because CBP can interact independently with required for effective ligand-dependent gene activation by nuclear receptors. A crucial role of CBP in ligandnuclear receptors, p160, and the related family members, it is likely that interactions between these proteins dependent activation events is supported by the observations that ligand-dependent association between are involved in transactivation events. Thus, one function of a nuclear receptor coactivator, such as p160, CBP and nuclear receptors occurs both in intact cells and on DNA-bound receptor complexes and that anticould be to increase the specificity and strength of interaction of nuclear receptors with members of the CBP CBP antibodies selectively inhibit the transcriptional activities of nuclear receptors in intact cells. Furthermore, family, potentially providing a direct link to the core transcriptional machinery (Drapkin et al., 1993) , analoincreased levels of CBP selectively permit thyroid hormone-dependent transcription in vitro, indicating that gous to the independent contacts proposed in synergistic interactions between transcription factors bound this factor is rate limiting in nuclear extracts. Thus, the identical criteria that have linked CBP to transactivation to distinct DNA sites (Hansen and Tjian, 1995) . The existence of CBP and p300, and of multiple SRC-related by CREB and Jun/Fos (Arias et al., 1994; Kwok et al., 1994) have been fulfilled for ligand-dependent gene actinuclear receptor coactivators, provides a potential combinatorial code for imparting receptor, DNA site, and vation, indicating that CBP plays a comparable role in nuclear receptor transactivation events. polarity specificity. The presence of a canonical bromodomain in CBP and p300, but not in p160/SRC-1 factors, While these surprising results implicate members of the CBP/p300 family as required for transcriptional actisuggests that a component of the requirement for CBP/ p300 might reflect actions on chromatin structure comvation by nuclear receptors, they are not likely alone to be sufficient. A series of additional potential nuclear parable with the actions proposed in SWI/SIN control of gene expression (e.g., Peterson and Herskowitz, 1992; receptor coactivators have been identified and reported (Cavailles et al., 1994; Halachmi et al., 1994; Lee et al., Winston and Carlson, 1992). 1995; Le Dourain et al., 1995; Oñ ate et al., 1995) The identification of CBP as an integral component of the activation complex for nuclear receptors obviously al., 1995). Because nuclear receptors function well in can be abolished by raising the levels of CBP, regulation of CBP expression is likely to be of critical importance in determining the transcriptional consequences of simultaneous activation of multiple pathways. Indeed, evidence that CBP is physiologically maintained at a limiting concentration is strongly suggested by the observation that individuals heterozygous for a truncated CBP transcription unit exhibit severe developmental defects, the Rubinstein-Taybi syndrome (Petrij et al., 1995) .
The observation that the interaction of CBP with nuclear receptors not only involves a direct contact with the nuclear receptor ligand-binding domain, but also a simultaneous interaction with p160, suggests that comparable coactivators will be required for other classes of transcription factors. For example, studies of CREB have indicated that, while necessary, interaction with tein reveals that it contains a region that is homologous to the PAS domain of the growing family of PAS/basicsuggests a molecular mechanism by which nuclear rehelix-loop-helix (bHLH) factors (Hankinson, 1995) . This ceptors might inhibit AP-1 action, based on a requirefamily includes the dioxin receptor and hypoxia-inducment for the relatively low intracellular levels of the CBP/ ible factor, which bind as heterodimers with ARNT to p300 family proteins by both classes of transcription asymmetric DNA response elements. The PAS domain factors. Because increasing the intracellular levels of is established to be a bipartite dimerization interface, this family of coactivators serves to abolish RAR or GR suggesting an intriguing linkage of p160/CBP integration repression of AP-1, and because AP-1 can effectively to a second, structurally distinct family of heterodimeric bind to RAR-associated CBP, it is likely that the limiting transcription factors, of which at least one is ligand amount of the CBP family factors is partitioned by the regulated. Further, these HLH factors may directly interalternative activation of nuclear receptors by ligand, or act with CBP, completing the parallel to nuclear recepof AP-1 by phosphorylation. Although a competition tors. Thus, the same integrator complex partners may model provides a mechanism for the observed antagomediate transactivation by nuclear receptors and PAS/ nism between nuclear receptors and AP-1 on genes that HLH factors. contain binding sites for only one class of factor, they do
We propose that the CBP/coactivator complexes be not account for the more complex pattern of regulation referred to as "integrators" based on their role in deobserved for genes containing composite response eletermining the relative transcriptional responses of a spements, as studied most extensively in the case of the cific target gene in the face of activation of multiple proliferin gene (Lefstin et al., 1994) . In this case, nuclear signaling pathways. The relative abilities of coactivators receptors and AP-1 protein can act either cooperatively to recruit limiting amounts of CBP into integrator comor antagonistically, depending upon the identity and plexes could account for aspects of the multifactorial conformation of the nuclear receptor (i.e., GR or mineralcontrol of biological processes under regulation of multiocorticoid receptor) and AP-1 complex (Jun/Jun or Jun/ ple signal transduction pathways. Thus, the precise coFos) bound to the composite element. It is possible that hort of genes activated in a given cell will depend on on such an element, some combinations of coactivators both the relative activity of diverse signaling pathways promote, while others inhibit, the recruitment of CBP.
and the organization and relative affinity of the complex on various DNA-bound factors that utilize CBP as a The CBP/p300 Family as Functional Integrators coactivator (see Figure 7) . Synergy might be expected of Diverse Signal Transduction Pathways on some promoters, while competitive interaction would The demonstration that CBP is required for transcripbe expected for others that contain only a subset of tional activation by CREB, AP-1, and nuclear receptors, sites for interacting transcription factors. Thereby, the and that these factors compete with each other to inter-CBP/p300 family serves to integrate the signals of diact with limiting amounts of CBP within the cell, sugverse growth factors, hormones, and intracellular ligests that CBP functions as a nuclear integrator of multigands that combinatorially modulate homeostasis and ple signal transduction pathways (Figure 7) . Because the antagonistic effects of nuclear receptors and AP-1 proliferation.
Experimental Procedures
constructed from human macrophage and mouse pituitary libraries, as described (Vinson et al., 1988) . Yeast Two-Hybrid Assay and Interaction Assays Yeast strain EGY48, the LexA-␤-galactosidase reporter construct Immunoprecipitation (pSH18-34), and the LexA and B42 parental vectors (pEG202 and EBNA cells (293) were transfected with pCEP4 CBP containing a pJG4-5) were as reported previously (Gyuris et al., 1993) . PCR frag-C-terminal in-frame FLAG epitope, (EYKEEEK)2. Where required, ments of rat T3R␣1 (122-410 and E403Q), human RAR␣ (143-462 RSV-RAR or GR was cotransfected. Immunoprecipitation and deand 143-403; ⌬403 and G303E), mouse RXR␥ (227-463 and E454Q), tection were performed as previously described . and human ER (251-595) were subcloned into pEG202 bait vector. cDNA encoding the CBP holoprotein was isolated from a mouse Acknowledgments pituitary cDNA library (Lin et al., 1992) . DNA fragments encompassing the entire CBP protein were subcloned into the pJG4-5
The first four authors have contributed critical independent aspects, prey vector. ␤-Galactosidase activity was determined as described permitting presentation of an integrated study. We also acknowlpreviously (Ausubel et al., 1994) . Ligands used in the yeast twoedge Peng Li for her contributions, Marcus Boehm for development hybrid assays were 10 Ϫ7 M TRIAC for T3R, 10 Ϫ7 M TTNPB for RAR, of synthetic ligands, David Livingston for the p300 cDNA clone, 10 Ϫ7 M LG69 for RXR, and 10 Ϫ7 M ␤-estradiol for ER. Protein-protein Tina-Marie Mullen for excellent technical assistance, Mathias Treier interaction assays using GST fusion proteins were performed as for critical review, and Beth Stawiarski for help in preparation of previously described Eckner, R. (1994) . E1A-dium, calf serum, was replaced with DMEM containing 10% charassociated p300 and CREB-associated CBP belong to a conserved coal-stripped serum. Plasmid DNAs were transfected into HeLa cells family of coactivators. Cell 77, 799-800. with standard calcium phosphate precipitation procedure (Gorman Arany, Z., Newsome, D., Oldread, E., Livingston, D.M., and Eckner, et al., 1982) . Typically, 1 g of TRE-driven reporter, 1 g of RSV-R. (1995) . A family of transcriptional adaptor proteins targeted by RXR␣ or GR, and 2 g of CMV-CBP or CMV-p300 were used, the the E1A oncoprotein. Nature 374, 81-84. final DNA concentration was adjusted to 5 g per 60 mm dish, and Arias, J., Alberts, A.S., Brindle, P., Claret, F.X., Smeal, T., Karin, M., TPA (Sigma) was administered at a final concentration of 100 ng/ Feramisco, J., and Montminy, M. (1994) . Activation of cAMP and ml in the presence or absence of all-trans retinoic acid, LG550, mitogen responsive genes relies on a common nuclear factor. Nature LG629, or dexamethasone at indicated concentrations.
370, 226-229.
Nuclear Microinjection, Staining, Ausubel, F.M., Brent, R., Kingston, R.E., Moore, D.D., Seidman, J.G., and Fluorescence Microscopy Smith, J.A., and Struhl, K. (1994) . Current Protocols in Molecular Insulin-responsive Rat-1 fibroblasts were seeded on acid-washed Biology (New York: Greene Publishing Association). glass coverslips at subconfluent density and grown in MNE/F12 Baniahmad, A., Leng, X., Burris, T.P., Tsai, S.Y., Tsai, M.J., and medium supplemented with 10% fetal bovine serum, gentamicin, O'Malley, B.W. (1995) . The tau4 activation domain of the thyroid and methotrexate. Prior to the injection, the cells were rendered hormone receptor is required for release of a putative corepressor(s) quiescent by incubation in serum-free medium for 24-36 hr. Plasnecessary for transcriptional silencing. Mol. Cell. Biol. 15, 76-86. mids were injected into the nuclei of cells at a final concentration Bannister, A.J., and Kouzarides, T. (1995) . CBP-induced stimulation of 100 g/ml. Either preimmune rabbit IgG or anti-CBP antibody of c-Fos activity is abrogated by E1A. EMBO J. 14, 4758-4762. (Santa Cruz Biotechnology) was coinjected and allowed the unambiguous identification of the injected cells. Microinjections were Beato, M., Herrlich, P., and Schü tz, G. (1995) . Steroid hormone recarried out using an Eppendorf semiautomated microinjection sysceptors: many actors in search of a plot. Cell 83, 851-857. tem mounted on an inverted Zeiss microscope. Approximately 1 hr Bourguet, W., Ruff, M., Chambon, P., Gronemeyer, H., and Mortas, after injection, the cells were stimulated where indicated with 10 Ϫ6 D. (1995) . Crystal structure of the ligand-binding domain of the hu-M all-trans retinoic acid (Sigma). After overnight expression, the man nuclear receptor RXR␣. Nature 375, 377-382. cells were fixed with 3.7% formaldehyde and then stained to detect Brindle, P., Linke, S., and Montminy, M. (1993). Protein-kinase-Ainjected IgG and ␤-galactosidase expression (Rose et al., 1992) . The dependent activator in transcription factor CREB reveals new role latter was detected by incubation with 5-bromo-4-chloro-3-indolylfor CREM repressors. Nature 364, 821-824. ␤-D-galactoside (X-Gal). Injected cells were identified by staining with tetramethylrhodamine-conjugated donkey anti-rabbit IgG.
Bugge, T.H., Pohl, J., Lonnoy, O., and Stunnenberg, H.G. (1992) . Cells were viewed and the results were analyzed on a Zeiss Axiophot RXR␣, a promiscuous partner of retinoic acid and thyroid hormone microscope. Photomicrographs were taken with the same equipreceptors. EMBO J. 11, 1409-1418. ment using Kodak Ektachrome 400 color film.
Cavailles, V., Dauvois, S., Danielian, P.S., and Parker, M.G. (1994) . Interaction of proteins with transcriptionally active estrogen recepIsolation of p160 cDNA Clones tors. Proc. Natl. Acad. Sci. USA 91, 10009-10013. Expression screening was performed essentially as described previously (Kaelin et al., 1992), using gt11 cDNA expression libraries Cavailles, V., Dauvois, S., L'Horset, F., Lopez, G., Hoare, S., Kushner,
